Procter & Gamble Health has appointed Shashank Srowthy as Chief Financial Officer to lead financial strategy, strengthen governance, and support sustainable business growth.
Shashank Srowthy has been appointed Chief Financial Officer
of Procter & Gamble Health, bringing extensive expertise in finance,
accounting, and business strategy. With a strong background in financial
management for global enterprises, Srowthy has a proven track record of
optimizing financial operations, driving strategic investments, and ensuring
robust governance across complex organizations.
As CFO, Srowthy oversees financial planning, reporting, risk
management, and capital allocation for Procter & Gamble Health. He is
responsible for developing strategies that enhance operational efficiency,
maximize shareholder value, and support the company’s growth objectives.
Srowthy collaborates with cross-functional leaders to align financial strategy
with business operations, ensuring informed decision-making and sustainable
performance.
Srowthy’s leadership emphasizes transparency,
accountability, and strategic foresight. By implementing data-driven financial
processes, he ensures that P&G Health remains agile, financially sound, and
well-positioned to invest in innovation, market expansion, and long-term value
creation. His appointment strengthens the company’s executive leadership team
and reinforces its commitment to operational excellence, strategic growth, and
financial discipline.